Details for New Drug Application (NDA): 012015
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
NDA 012015 describes COGENTIN, which is a drug marketed by Akorn and Merck and is included in two NDAs. Additional details are available on the COGENTIN profile page.
The generic ingredient in COGENTIN is benztropine mesylate. There are seven drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the benztropine mesylate profile page.
The generic ingredient in COGENTIN is benztropine mesylate. There are seven drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the benztropine mesylate profile page.
Summary for 012015
| Tradename: | COGENTIN |
| Applicant: | Akorn |
| Ingredient: | benztropine mesylate |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 012015
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
